Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 13/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 13/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | EDNRA | P25101 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7371129 | 0.81 | MTNR1B (0.54) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL5304699 | 0.80 | MTNR1A (0.56) | MTNR1AMTNR1BALDH1A1CES2CES1 | |
| SCHEMBL5992093 | 0.78 | MTNR1A (0.57) | MTNR1AMTNR1BALDH1A1CES2CES1 | |
| SCHEMBL6960077 | 0.77 | KIF11 (0.40) | LMNAPARP1 | |
| SCHEMBL10297508 | 0.77 | MTNR1A (0.55) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL10702424 | 0.75 | MAPT (0.55) | MTNR1AMTNR1BALDH1A1LMNA | |
| SCHEMBL10426256 | 0.75 | MTNR1A (0.51) | MTNR1AMTNR1BLMNA | |
| SCHEMBL7461488 | 0.75 | MTNR1A (0.54) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL28470846 | 0.74 | MTNR1A (0.55) | MTNR1AMTNR1BCES2CES1EDNRA | |
| SCHEMBL6958711 | 0.74 | CYP2C9 (0.43) | ALDH1A1LMNAPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0729465-B1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE DAVIS & CO (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6005103-A | TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS | WARNER-LAMBERT COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| US-5808062-A | AIDS THERAPY | WARNER-LAMBERT COMPANY (US) | 1998-09-15 | — | — | US | disclosed |